Literature DB >> 3138191

Therapy of experimental listeriosis--an evaluation of different antibiotics.

H Hof1, G Waldenmeier.   

Abstract

The therapeutic activities of various antibiotics were evaluated in two murine models, i.e. the infection of normal mice as well as of nude mice. Coumermycin and rifampicin were the most active drugs, since not only inhibition of multiplication but also rapid elimination of Listeria monocytogenes could be achieved in normal and immunocompromised animals. Ampicillin was the most active beta-lactam antibiotic followed by azlocillin. The other beta-lactam antibiotics were definitely less active. The combination of ampicillin with gentamicin expressed no synergistic effect in vivo. Co-trimoxazole as well as ciprofloxacin were of moderate therapeutic value. The bacteriostatic drugs such as tetracycline and erythromycin were able to inhibit the bacterial multiplication in the normal mouse but not in the immunocompromised host. Thus an optimal drug for therapy of listeriosis does not yet exist.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3138191     DOI: 10.1007/bf01639743

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  The effect of coumermycin on experimental listeriosis.

Authors:  H Hof
Journal:  J Infect       Date:  1986-07       Impact factor: 6.072

2.  Infection of HeLa cells with Salmonella typhimurium 395 MS and MR10 bacteria.

Authors:  E Kihlström
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Lack of synergism of ampicillin and gentamicin in experimental listeriosis.

Authors:  H Hof; H Gückel
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

Review 4.  The role of T cell subpopulations in cell mediated immunity to facultative intracellular bacteria.

Authors:  M Mielke; S Ehlers; H Hahn
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  Rifampicin and rifapentine in treatment of experimental listeriosis in normal mice and athymic (nude) mice.

Authors:  I A Bakker-Woudenberg; P de Bos; M F Michel
Journal:  Chemotherapy       Date:  1984       Impact factor: 2.544

6.  Murine model for therapy of listeriosis in the compromised host. I. Effect of ampicillin.

Authors:  H Hof; P Emmerling; H P Seeliger
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

7.  Evaluation of rifampin and other antibiotics against Listeria monocytogenes in vitro and in vivo.

Authors:  W M Scheld
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

8.  Murine model for therapy of listeriosis in the compromised host. III. The effect of rifampicin.

Authors:  H Hof; P Emmerling
Journal:  Chemotherapy       Date:  1984       Impact factor: 2.544

9.  Immunologic consequences of antibiotic-induced abridgement of bacterial infection: effect on generation and loss of protective T cells and level of immunologic memory.

Authors:  R J North; P A Berche; M F Newborg
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

10.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

View more
  11 in total

1.  Effect of various antibiotics on Listeria monocytogenes multiplying in L 929 cells.

Authors:  T Nichterlein; H Hof
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Listeria Monocytogenes infections.

Authors:  R C Gordon
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

3.  Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes.

Authors:  Gitte M Knudsen; Yin Ng; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2013-09-20       Impact factor: 4.792

4.  Inhibition of intracellular growth of Listeria monocytogenes by antibiotics.

Authors:  C Michelet; J L Avril; F Cartier; P Berche
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

5.  Bactericidal antibiotics do not appear to cause oxidative stress in Listeria monocytogenes.

Authors:  Louise Feld; Gitte M Knudsen; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

Review 6.  Listeria monocytogenes infections--therapeutic possibilities and problems.

Authors:  W Marget; H P Seeliger
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 7.  Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

Authors:  E M Jones; A P MacGowan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

8.  Rapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosis.

Authors:  Solène Grayo; Marie-Catherine Lott-Desroches; Olivier Dussurget; Renaud Respaud; Arnaud Fontanet; Olivier Join-Lambert; Eric Singlas; Alban Le Monnier
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

Review 9.  Therapeutic activities of antibiotics in listeriosis.

Authors:  H Hof
Journal:  Infection       Date:  1991       Impact factor: 3.553

10.  Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.

Authors:  Stéphane Carryn; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.